23 May 2013
Keywords: Biotie, Synosia, M&A, UCB
Article | 11 January 2011
Finland-based biotech firm Biotie Therapies (Nasdaq-OMX; BTH1V) has signed an accord to acquire privately-held Swiss company Synosia Therapeutics Holding ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 January 2011
22 May 2013
© 2013 thepharmaletter.com